New supplement study tests how body handles saninova
NCT ID NCT07664657
First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 4 times
Summary
This trial will give 32 healthy adults a single dose of Saninova tablets, which contain Vitamin C, Vitamin B2, and Astragalus root extract. Researchers will measure how much of these ingredients get into the blood and how quickly the body clears them. The goal is to understand the supplement's pharmacokinetics, not to treat any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Saninova tablets (Vitamin C, Vitamin B2, Astragalus Root dry extract)
What this could lead to
If successful, this study will show how the body absorbs and processes Saninova tablets, helping to determine proper dosing.
What could go wrong
This is a very early, small study in healthy people, not patients. It only measures drug levels, not whether the supplement works for any condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIOAVAILABILITY AND PHARMACOKINETICS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinispec Research Pvt Ltd
Hyderabad, Telangana, 500043, India